Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dengue and leishmaniasis, high priorities in Brazil:

This article was originally published in Clinica

Executive Summary

The diagnosis of Dengue fever and leishmaniasis remain high priorities of the Brazilian health ministry. The national healthcare foundation - Fundacao Nacional de Saude (Funasa) - has announced that it is continuing to train healthcare surveillance personnel specialised in these two mosquito-borne viral diseases. The last several months have seen the worst dengue epidemic in recorded history (see Clinica No 1001, p 14). In January 2002 alone, Funasa trained around 89,000 dengue surveillance agents, in a bid to improve early detection and treatment of the disease. Leishmaniasis is currently present in 19 states, with 90% of cases reported in the Northwest region.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067604

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel